CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 169 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02180906
NCT02180906N/ACompleted
CompareCT.gov

Biomarkers in Necrotizing Soft Tissue Infections - Aspects of the Innate Immune Response

Ole Hyldegaard·observational·Posted Jul 3, 2014·Updated Feb 17, 2016

In Brief

An observational study for Necrotizing Soft Tissue Infection and 3 related conditions. Completed, enrolled 169 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate the immune response in patients with necrotizing soft tissue infections (NSTI). The investigation will focus on inflammatory and vasoactive biomarkers as prognostic markers of severity and mortality at admission to Rigshospitalet and the following 3 days

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNecrotizing Soft Tissue Infection, Necrotizing Fasciitis, Gas Gangrene, Fournier Gangrene
CountriesDenmark
CollaboratorsSeventh Framework Programme

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJul 3, 2014
Enrollment StartFeb 1, 2013
Primary CompletionFeb 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 12.0 years ago